Brinker International, Inc. To Host Third Quarter Fiscal 2018 Earnings Call
Adamis Pharmaceuticals Updates Symjepi Commercialization Plans
Brinker International Board Declares Common Dividend
Brinker International Reports Second Quarter Results
Brinker International, Inc. To Host Second Quarter Fiscal 2018 Earnings Call
Brinker International Adds James Katzman To Board Of Directors, Bringing Financial And Business Expertise
Brinker International and Pearson Partner to Offer No Cost Education to Chili's and Maggiano's Employees
Brinker International Names Wade Allen As Chief Digital Officer
Adamis Pharmaceuticals Announces Submission of Investigational New Drug (IND) Application to the FDA for New Product Candidate for the Treatment of Opioid Overdose
Brinker International Board Declares Common Dividend
 50   51   52   53   54     55    56   57   58   59   60 
 <<   <   >   >>